High fibrinogen-to-albumin ratio powerful predictor of adverse outcomes in CAD patients
An original article was published in the Journal of Cardiovascular Translational Research on June 22. "The Fibrinogen-to-Albumin Ratio Is Associated with Poor Prognosis in Patients with Coronary Artery Disease: Findings from a Large Cohort" by Hou et al. and colleagues has discussed the association of FAR or fibrinogen-to-albumin ratio (FAR) with the clinical outcomes of coronary artery disease (CAD).
Patients with CAD history were from a prospective cohort which recruited 15,250 patients admitted to the First Affiliated Hospital of Xinjiang Medical University between December 2016 and October 2021.
Fourteen thousand nine hundred ninety-four patients enrolled were divided into two groups using ROC curve analysis. The primary endpoints were all-cause mortality (ACM) and cardiac mortality (CM), and secondary endpoints were major adverse cardiovascular events (MACEs), major adverse cardiac and cerebrovascular events (MACCEs), and non-fatal myocardial infarction (NFMI).
The study summary draws the following considerations:
- There were 10,076 participants in the low-FAR group and 4918 in the high-FAR group.
- Researchers compared the incidence of outcomes between the two groups.
- High-FAR group exhibited a higher incidence of ACM (5.3% vs 1.9%), CM (3.9% vs 1.4%), MACEs (9.8% vs 6.7%), MACCEs (10.4% vs 7.6%), and NFMI (2.3% vs 1.3%) when compared to the low-FAR group.
- The risk in the high-FAR group was increased by 2.182 fold in ACM, 2.116 fold in CM, 1.327 fold in MACEs, 1.280 fold in MACCEs and 1.791 fold in NFMI to the low-FAR group.
They concluded by saying, “High FAR group is an independent and powerful predictor of adverse outcomes in Coronary Artery Disease patients.”
Further reading:
https://link.springer.com/article/10.1007/s12265-023-10402-9
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.